Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pioglitazone for the Treatment of Major Depressive Disorder Comorbid With Metabolic Syndrome

NCT00671515 is registered in ClinicalTrials.gov with Joseph Calabrese, MD as lead sponsor.

NCT NCT00671515
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00671515 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pioglitazone for the Treatment of Major Depressive Disorder Comorbid With Metabolic Syndrome
Lead sponsor
Joseph Calabrese, MD
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2008
Completion date
November 30, 2011
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depressive disorder, major, metabolic syndrome x